Self-powered microchips for rapid diagnosis and severity determination of urinary tract infections

Children presenting a fever without known sources are usually checked for bacterial urinary tract infection (UTI) which, in its more complicated forms, can result in permanent kidney damage. The gold standard conventional tests to diagnose complicated urinary tract infections are urine culture and kidney imaging with a radioactive tracer. However, these tests are lengthy (urine culture can take up to 48 hours to provide results) and expensive. Our aim is to develop self-powered, portable, and disposable microchips that directly detect bacterial pathogens in urine and measure blood protein biomarkers of kidney damage. Such microchips would allow rapid, sensitive, inexpensive, and minimally-invasive diagnosis of UTI as well as determination of infection severity. In addition, the developed microchips will provide immediate and high-quality diagnosis to guide clinical decisions and treatments thereby improving Canadian healthcare. TO BE CONt’D

Faculty Supervisor:

David Juncker

Student:

Partner:

Sensoreal Inc

Discipline:

Engineering

Sector:

Manufacturing; Professional, scientific and technical services

University:

McGill University

Program:

Elevate

Related projects

Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.

View all
Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects

Mitacs Partners

The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.

Government
Academic
Industry
Innovation
International

International

Load More

International

Load More

Join a thriving innovation ecosystem.

Subscribe to our newsletter now!

Subscribe

Mitacs — Return on Innovation

Mitacs is funded by the Government of Canada, the Government of Alberta, the Government of British Columbia, Research Manitoba, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, Innovation PEI, the Government of Quebec, the Government of Saskatchewan, and the Government of Yukon.